You are here

• Home
• About AstraZeneca US
• Newsroom

• Research news

The following shows headlines of research-related news articles published within 12-months, starting from most recent.

• Pages
• 1
• 2
• Next

• • Jul 28, 2010
  • FDA Advisory Committee recommends US FDA approval of BRILINTA (ticagrelor) for Acute Coronary Syndromes  
• • Jun 26, 2010
  • Dapagliflozin as add on therapy to insulin demonstrated improved glycemic control in patients with type 2 diabetes inadequately controlled with insulin  
• • Jun 23, 2010
  • AstraZeneca and Targacept initiate Phase 3 clinical development of TC-5214 as an adjunct treatment for major depressive disorder  
• • Jun 22, 2010
  • Dapagliflozin as monotherapy demonstrated improved glycemic control in treatment-naïve adults with type 2 diabetes  
• • Jun 7, 2010
  • First phase III trial with definitive results in advanced medullary thyroid cancer shows statistically significant extension of progression free survival for patients  
• • May 14, 2010
  • Phase II data contributes to understanding of cediranib in recurrent glioblastoma  
• • Mar 30, 2010
  • AstraZeneca and Abbott receive FDA complete response letter on CERTRIAD™ New Drug Application  
• • Mar 16, 2010
  • New PLATO sub-analysis of CABG patients presented at ACC  
• • Jan 18, 2010
  • AstraZeneca and Dako sign agreement to develop companion diagnostics for cancer treatments  
• • Dec 15, 2009
  • AstraZeneca and the University of Virginia sign strategic research collaboration to develop novel treatments for cardiovascular disease  

• Pages
• 1
• 2
• Next

Page tools

• Print
• Bookmark this page
• Subscribe to RSS news feed